We are a clinician-led team that believes a close collaboration between clinicians and engineers is essential to building technology that is effective for both patients and providers.

Senior Management

  • Mark is a neuroscientist and neurologist with experience in teleneurology and telestroke. He has spent over a decade exploring the use of new technology to improve stroke care.

Mark McDonald, MS, MD

  • Omar is an engineer who worked in industry before obtaining his medical degree. He is experienced in managing multi-disciplinary teams and has spent the last 7+ years working at the intersection of stroke and AI.

Omar Uribe, MD


  • In 20+ years in healthcare tech, Ben has served as CTO for 6 investor-backed companies, and is currently an Oxford University Med Device Expert in Residence.

Ben Wensley-Stock

  • Elizabeth is an occupational therapist specializing in stroke recovery. Her clinical work along with her technology marketing experience help her present Syntrillo’s platform in an accessible way to stroke survivors.

Elizabeth King, MS, OTR/L

  • Brett has been CEO for two investor-backed SaaS companies. He brings his experience as an international tech M&A lawyer, a senior executive of a publicly-traded company, and a digital health investment banker. He has also been a board member of six investor backed companies.

Brett Mankey, JD, LLM

Board of Directors

  • Mark is a neuroscientist and neurologist with experience in teleneurology and telestroke. He has spent over a decade exploring the use of new technology to improve stroke care.

Mark McDonald, MS, MD

  • Omar is an engineer who worked in industry before obtaining his medical degree. He is experienced in managing multi-disciplinary teams and has spent the last 7+ years working at the intersection of stroke and AI.

Omar Uribe, MD

  • Brett has been CEO for two investor-backed SaaS companies. He brings his experience as an international tech M&A lawyer, a senior executive of a publicly-traded company, and a digital health investment banker. He has also been a board member of six investor backed companies.

Brett Mankey, JD, LLM

  • Snehal received MD/JD from Columbia and was a clinical fellow and Fulbright scholar at the Harvard Medical School. Co-Founder and CEO of MyDoc - chronic disease management platform with a successful exit in 2022.

Snehal Patel, JD, MD

  • Syntrillo investor and the Chairman of GaitQ, AI and med device company transforming the management of Parkinson’s disease. Founding partner of Fundsmith, a retail fund management business that he helped grow to +40B GBP AUM.

Simon Godwin